Improving medical adherence in atopic eczema treatments

Abstract

Atopic eczema (AE) is an increasingly prevalent and impactful skin condition that significantly affects the lives of both the patient affected by it and their caregivers. The symptoms of AE, such as persistent itching and discomfort, can have an extensive negative impact on the emotional well-being and overall quality of life of those affected by it, thus making effective management crucial. Several barriers, including child resistance, misconceptions among caregivers, and the time-consuming treatment, contribute to low treatment adherence. To address this challenge and contribute to the enhancement of treatment adherence in (childhood)AE, this project aims to develop supportive tools that enable caregivers to apply treatments in a more efficient, accurate, and enjoyable way.

This project is being conducted in collaboration with Erasmus Medical Center while adhering to the design thinking process. This process involves empathizing with the design problem and target group, as well as (physically) exploring and validating proposed concepts. Throughout these design stages, a range of methodologies was employed, including literature research, field observations, morphological charting, and expert and user interviews. The report details the steps taken in designing two supportive tools aimed at improving the treatment experience and adherence for individuals with atopic eczema (AE).

The initial tool developed in this project is a device aiding a more precise dosing mechanism. It serves as a translation of existing application methodologies. The purpose of this product is to reduce treatment mismatch caused by a lack of understanding of dosing methodologies, thereby addressing non-adherence issues. The dosing mechanism is meant to act as a universal solution, compatible with existing cream and ointment tubes.

Furthermore, the second tool is specifically designed to complement the first tool by providing a visual representation of the appropriate skin surface for each dosed unit. The concept also incorporates various textures to allow for the comparison of healthy skin versus AE-affected skin. By shaping the measurement tool in the form of a stuffed animal, it contributes to heightened relatedness to the child, while also involving them in the treatment process.

Drawing from the comprehensive user and expert research, this report establishes future recommendations for the further development of the concepts. Additionally, a roadmap is provided to bring structure to and help prioritize these recommendations. Both concepts demonstrate promising results, indicating the need for further research and elaboration.